INSM (Insmed Inc) may reap gains as insiders became active recently

Samantha Gray

Insmed Inc’s filing revealed that its Chief People Strategy Officer Schaeffer Orlov S Nicole unloaded Company’s shares for reported $11.13 million on Sep 12 ’25. In the deal valued at $145.45 per share,76,520 shares were sold. As a result of this transaction, Schaeffer Orlov S Nicole now holds 36,461 shares worth roughly $5.98 million.

Then, SHAROKY MELVIN MD sold 10,000 shares, generating $1,453,900 in total proceeds. Upon selling the shares at $145.39, the Director now owns 262,675 shares.

Before that, Schaeffer Orlov S Nicole bought 76,520 shares. Insmed Inc shares valued at $11,127,662 were divested by the Officer at a price of $145.42 per share.

Wells Fargo initiated its Insmed Inc [INSM] rating to an Overweight in a research note published on October 20, 2025; the price target was $171. A number of analysts have revised their coverage, including William Blair’s analysts, who began to cover the stock in mid August with a ‘”an Outperform”‘ rating. Morgan Stanley also remained covering INSM and has decreased its forecast on August 13, 2025 with a “an Equal-weight” recommendation from previously “an Overweight” rating. Jefferies started covering the stock on May 13, 2025. It rated INSM as “a Buy”.

Price Performance Review of INSM

On Monday, Insmed Inc [NASDAQ:INSM] saw its stock jump 2.73% to $164.02. Over the last five days, the stock has lost -2.32%. Insmed Inc shares have risen nearly 128.00% since the year began. Nevertheless, the stocks have risen 137.57% over the past one year. While a 52-week high of $168.21 was reached on 10/20/25, a 52-week low of $60.40 was recorded on 04/09/25.

Levels Of Support And Resistance For INSM Stock

The 24-hour chart illustrates a support level at 161.65, which if violated will result in even more drops to 159.29. On the upside, there is a resistance level at 165.26. A further resistance level may holdings at 166.50.

How much short interest is there in Insmed Inc?

A steep rise in short interest was recorded in Insmed Inc stocks on 2025-10-15, dropping by -1.09 million shares to a total of 9.48 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-15 was 10.58 million shares. There was a decline of -11.54%, which implies that there is a negative sentiment for the stock.

The most recent change occurred on February 25, 2025 when RBC Capital Mkts began covering the stock and recommended ‘”an Outperform”‘ rating along with a $100 price target.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.